Načítá se...
Use of AAV Vectors for CRISPR-Mediated In Vivo Genome Editing in the Retina
Degenerative retinal diseases such as retinitis pigmentosa (RP) and Leber’s congenital amaurosis (LCA) may lead to blindness without effective treatment. With the rapid advancement of the CRISPR/Cas9 genome editing technology, in vivo application of CRISPR/Cas9 holds immense potential for treatment...
Uloženo v:
| Vydáno v: | Methods Mol Biol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6730636/ https://ncbi.nlm.nih.gov/pubmed/30783971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/978-1-4939-9139-6_7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|